e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Adverse events of antituberculosis treatment and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Outcomes among patients with pulmonary TB with diabetes mellitus treated with anti-TB drugs of 1
st
line
G. Hauadamova, E. Arbuzova, Y. Besstrashnova, G. Akbaeva (Almaty, Kazakhstan)
Source:
Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Session:
Adverse events of antituberculosis treatment and comorbidities
Session type:
Thematic Poster Session
Number:
3145
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Hauadamova, E. Arbuzova, Y. Besstrashnova, G. Akbaeva (Almaty, Kazakhstan). Outcomes among patients with pulmonary TB with diabetes mellitus treated with anti-TB drugs of 1
st
line. Eur Respir J 2010; 36: Suppl. 54, 3145
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Effectiveness of lung surgery in MDR TB patients with diabetes mellitus
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016
Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004
Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Intensive chemotherapy of pulmonary tuberculosis in patients with diabetes mellitus
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004
Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Adverse events in the treatment of patients with pulmonary tuberculosis combined with diabetes mellitus and without it.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021
Effectiveness of mesodiencephalic modulation in treatment of XDR TB patients with concomitant type II diabetes mellitus
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Clinical features of pulmonary tuberculosis in patients with diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012
Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it.
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Impact of diabetes mellitus on MDR-TB outcome
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018
Impact of diabetes mellitus on pulmonary tuberculosis clinical presentation and treatment outcomes
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018
Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus
Source: International Congress 2017 – COPD management
Year: 2017
Tuberculosis and diabetes mellitus: Treatment outcomes using directly observed therapy (DOT)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Influence of diabetes mellitus on sputum conversion rate in pulmonary tuberculosis and on antituberculous drug resistance
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Mesodiencephalic modulation in the treatment of XDR TB patients with concomitant type II diabetes mellitus
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021
Impact of diabetes mellitus on drug-resistant tuberculosis treatment outcomes in Georgia – Cohort study
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Diabetes mellitus as cause of treatment failure and relapses of pulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 311s
Year: 2001
New approaches to surgical treatment of patients with tuberculosis of lungs revealed for the first time in combination with diabetes mellitus
Source: Annual Congress 2012 - Surgery for infections and congenital diseases
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept